News

Drug Duo Shows Promise in Treating Chronic Lymphocytic Leukemia

The treatment of chronic lymphocytic leukemia (CLL) is continuing to change, and shows no signs of slowing down, according to Alan Skarbnik, M.D., a staff physician at the Department of Bone Marrow Transplant, Department of Lymphoma in the John Theurer Cancer Center. “For the past several years, CLL has been an ever-changing landscape with newer and more effective drugs, so it is interesting to see where the field is headed,” Skarbnik said in an interview with OncLive, a sister publication of CURE.

Read full article on curetoday.com